Ethical issues in moral and social enhancement

Sociology of Health & Illness, 26
(1), 50–80. 
Burke, M. (2011). “Resisting pathology: GID and the contested terrain of diagnosis 
in the transgender rights movement.” In 
Sociology of Diagnosis
(Eds. 
McGann, P. and Hutson, D.). Bingley: Emerald Group Publishing.
Campbell, A. (2008). Attachment, aggression, and affiliation: The role of oxytocin 
in female social behavior. 
Biological Psychology, 77
(1), 1-10.
Canning, J. (1996). 
A History of Medieval Political Thought: 300–1450
. London, 
UK: Routledge.
Carritt, E. (1947). 
Ethical and political thinking
. Oxford: Oxford University Press.
Carter, A. and Hall, W. (2008). Informed consent to opioid agonist maintenance 
treatment: Recommended ethical guidelines. 
International Journal of Drug 
Policy, 19
(1), 79-89.
Carter, A. and Hall, W. (2012). 
Addiction neuroethics: The promises and perils of 
neuroscience research on addiction.
Cambridge: Cambridge University 
Press.
Carter, I. (2008). “How are power and unfreedom related?” In in 
Republicanism 
and Political Theory
, Laborde, C. and Maynor, J. (eds.). Malden, MA: 
Blackwell Publishing. 
Chan, S. and Harris, J. (2011). Moral enhancement and pro-social behaviour. 
Journal of Medical Ethics, 37
(3), 130-131.
Chisholm, R. (1966). “Freedom and action.” In 
Freedom and determinism
(Ed. 
Lehrer, K.) New York, NY: Random House.
Christman, J. (1991). Autonomy and personal history. 
Canadian Journal of 
Philosophy 20
, 1-24. 
Churchland, P. (2011). 
Braintrust: What neuroscience tells us about morality
. 
Princeton, NJ: Princeton University Press.
Clarke, A., Shim, J., Mamo, L., Fosket, J. and Fishman, J. (2003). 
Biomedicalization: Technoscientific transformations of health, illness, and 
U.S. biomedicine. 
American Sociological Review, 68,
161-194.
Cohen , J.B. and Goldberg , M.E. ( 1970 ). The dissonance model in post-decision 
product evaluation. 
Journal of Marketing Research , 11
, 315 – 321. 
Cole-Turner, R. (1998). “Do means matter?” In 
Enhancing human traits: ethical 
and social implications
(Ed. Parens, E.). Washington, DC: Georgetown 
University Press.
Conrad, P. (1975). The discovery of hyperkinesis: Notes on the medicalization of 
deviant behavior. 
Social Problems, 23
, 12–21. 
Conrad, P. (1992). Medicalization and social control. 
Annual Review of Sociology, 
18,
209-232.
Conrad, P. (2000). “Medicalization, genetics, and human problems.” In 
The 
Handbook of Medical Sociology, 5
th
ed
(Eds. Bird, C., Conrad, P. and 
Fremont, A.). Upper Saddle River, NJ: Prentice-Hall.

---

238 
Conrad, P. (2005). The shifting engines of medicalization. 
Journal of Health and 
Social Behavior, 46
, 3-14.
Conrad, P. (2007). 
The medicalization of society: On the transformation of human 
conditions into treatable disorders.
Baltimore, MD: John Hopkins 
University Press.
Conrad, P. and Potter, D. (2000). From hyperactive children to ADHD adults: 
Observations on the expansion of medical categories. 
Social Problems, 47
, 
559-382. 
Conrad, P. and Schneider, J. (1980). 
Deviance and medicalization: From badness 
to sickness. 
Philadelphia, PA: Temple University Press.
Conrad, P., Mackie, T. and Mehrotra, A. (2010). Estimating the costs of 
medicalization.